Chemical Structure (Image 01)
Librax Capsule
Product Images NDC 0187-4100
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Librax (NDC 0187-4100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bausch Health Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Image 02)
Image 03
Librax is a medication containing chlordiazepoxide hydrochloride and clidinium bromide. It comes in capsules, and each capsule contains 5 g chiordiazepoxide hydrochioride and 2.5 mg clidinium bromide. The usual adult dosage is one or two capsules 3 or 4 times a day, before meals and at bedtime. It is important to keep this medication out of reach of children and store it at 25°C (77°F), with excursions permitted o 15°C to 30°C (59°F to 86°F). This medication should be dispensed in a tight, light-resistant container as defined in USPINF. It is distributed by Bausch Health US, LLC and manufactured by Bausch Health Companies Inc, in Steinbach, MB BSG 177, Canada. A medication guide is included with each prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
